Prescription and dosing of urate-lowering therapy, rather than patient behaviours, are the key modifiable factors associated with targeting serum urate in gout

Prescription and dosing of urate-lowering therapy, rather than patient behaviours, are the key modifiable factors associated with targeting serum urate in gout

<p>Abstract</p> <p>Background</p> <p>Long term serum urate (SU) lowering to a target of <0.36 mmol/l (6 mg/dl) is recommended for effective gout management. However, many studies have reported low achievement of SU targets. The aim of this cross-sectional study was t...

Full description

Bibliographic Details
Main Authors: Dalbeth Nicola, House Meaghan E, Horne Anne, Petrie Keith J, McQueen Fiona M, Taylor William J
Format: Article
Language:English
Published: BMC 2012-09-01
Series:BMC Musculoskeletal Disorders
Subjects:
Gout
Urate
Target
Allopurinol
Online Access:http://www.biomedcentral.com/1471-2474/13/174

Similar Items

Similar Items